AHL Partners’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

AHL Partners’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-10,036	Closed	-$141K	–	1398
2017 Q3	$141K	Buy	+10,036	New	+$90.8K	﹤0.01%	1214

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AHL Partners's SPPI Position: Q4 2017 in Review

AHL Partners sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2017, closing a stake of 10,036 shares — an estimated $141K sold.

AHL Partners first reported a position in SPPI in Q3 2017 and held it in 1 quarter. The position peaked at $141K in Q3 2017. 157 funds tracked by Wall St. Rank hold SPPI as of Q4 2017.

AHL Partners reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
AHL Partners sold 10,036 Spectrum Pharmaceuticals Inc shares in Q4 2017, an estimated $141K.
AHL Partners first reported a position in Spectrum Pharmaceuticals Inc in Q3 2017 and held it in 1 quarter.
AHL Partners's Spectrum Pharmaceuticals Inc position peaked at $141K in Q3 2017.
157 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.